[1]
|
Writing Group M, Mozaffarian, D., Benjamin, E.J., et al. (2016) Heart Disease and Stroke Statistics—2016 Update: A Report from the American Heart Association. Circulation, 133, e38-e360.
|
[2]
|
Adams, H.P., Bendixen, B.H., Kappelle, L.J., et al. (1993) Classification of Subtype of Acute Ischemic Stroke. Definitions for Use in a Multicenter Clinical Trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 24, 35-41.
https://doi.org/10.1161/01.STR.24.1.35
|
[3]
|
Kim, Y.D., Cha, M.J., Kim, J., et al. (2011) Increases in Cerebral Atherosclerosis According to CHADS2 Scores in Patients with Stroke with Nonvalvular Atrial Fibrillation. Stroke, 42, 930-934.
https://doi.org/10.1161/STROKEAHA.110.602987
|
[4]
|
Kim, S.J., Ryoo, S., Kwon, S., et al. (2013) Is Atrial Fibrillation Always a Culprit of Stroke in Patients with Atrial Fibrillation plus Stroke? Cerebrovascular Diseases, 36, 373-382. https://doi.org/10.1159/000355571
|
[5]
|
Cha, M.J., Kim, Y.D., Nam, H.S., Kim, J., Lee, D.H. and Heo, J.H. (2012) Stroke Mechanism in Patients with Non-Valvular Atrial Fibrillation According to the CHADS2 and CHA2 DS2-VASc Scores. European Journal of Neurology, 19, 473-479. https://doi.org/10.1111/j.1468-1331.2011.03547.x
|
[6]
|
中华医学会神经病学分会. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(59): 666-682.
|
[7]
|
中国高血压防治指南修订委员会, 中华医学会心血管病学分会, 等. 中国高血压防治指南2018[J]. 中国心血管杂志, 2019, 24(1): 24-56.
|
[8]
|
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版) [J]. 中国实用内科杂志, 2018, 38(4): 292-344.
|
[9]
|
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会中华心血管病杂志编辑委员会. 中国心力衰竭诊断与治疗指南2018[J] 中华心血管病杂志, 2018, 46(10): 760-789.
|
[10]
|
Samuels, O.B., Joseph, G.J., Lynn, M.J., Smith, H.A. and Chimowitz, M.I. (2000) A Standardized Method for Measuring Intracranial Arterial Stenosis. American Journal of Neuroradiology, 21, 643-646.
|
[11]
|
(1991) North American Symptomatic Carotid Endarterectomy Trial. Methods, Patient Characteristics, and Progress. Stroke, 22, 711-720. https://doi.org/10.1161/01.STR.22.6.711
|
[12]
|
January, C.T., Wann, L.S., Calkins, H., et al. (2019) 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 74, 104-132. https://doi.org/10.1016/j.jacc.2019.01.011
|
[13]
|
Goldstein, L.B., Bertels, C. and Davis, J.N. (1989) Interrater Reliability of the NIH Stroke Scale. Archives of Neurology, 46, 660-662. https://doi.org/10.1001/archneur.1989.00520420080026
|
[14]
|
Hoole, S.P., Heck, P.M., White, P.A., et al. (2010) Stunning and Cumulative Left Ventricular Dysfunction Occurs Late after Coronary Balloon Occlusion in Humans Insights from Simultaneous Coronary and Left Ventricular Hemodynamic Assessment. JACC: Cardiovascular Interventions, 3, 412-418. https://doi.org/10.1016/j.jcin.2009.12.014
|
[15]
|
Cha, M.J., Lee, H.S., Kim, Y.D., Nam, H.S. and Heo, J.H. (2013) The Association between Asymptomatic Coronary Artery Disease and CHADS2 and CHA2 DS2-VASc Scores in Patients with Stroke. European Journal of Neurology, 20, 1256-1263. https://doi.org/10.1111/ene.12158
|
[16]
|
Granger, C.B., Alexander, J.H., McMurray, J.J., et al. (2011) Apixaban versus Warfarin in Patients with Atrial Fibrillation. The New England Journal of Medicine, 365, 981-992. https://doi.org/10.1056/NEJMoa1107039
|
[17]
|
Gage, B.F., Waterman, A.D., Shannon, W., Boechler, M., Rich, M.W. and Radford, M.J. (2001) Validation of Clinical Classification Schemes for Predicting Stroke: Results from the National Registry of Atrial Fibrillation. JAMA, 285, 2864-2870. https://doi.org/10.1001/jama.285.22.2864
|
[18]
|
Lip, G.Y., Frison, L., Halperin, J.L. and Lane, D.A. (2010) Identifying Patients at High Risk for Stroke Despite Anticoagulation: A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort. Stroke, 41, 2731-2738. https://doi.org/10.1161/STROKEAHA.110.590257
|
[19]
|
Puwanant, S., Varr, B.C., Shrestha, K., et al. (2009) Role of the CHADS2 Score in the Evaluation of Thromboembolic Risk in Patients with Atrial Fibrillation Undergoing Transesophageal Echocardiography before Pulmonary Vein Isolation. Journal of the American College of Cardiology, 54, 2032-2039. https://doi.org/10.1016/j.jacc.2009.07.037
|
[20]
|
Rietbrock, S., Heeley, E., Plumb, J. and van Staa, T. (2008) Chronic Atrial Fibrillation: Incidence, Prevalence, and Prediction of Stroke Using the Congestive Heart Failure, Hypertension, Age >75, Diabetes Mellitus, and Prior Stroke or Transient Ischemic Attack (CHADS2) Risk Stratification Scheme. American Heart Journal, 156, 57-64.
https://doi.org/10.1016/j.ahj.2008.03.010
|
[21]
|
Gallagher, R., Zhang, L., Roach, K., et al. (2015) Profile of Atrial Fibrillation Inpatients: Cardiovascular Risk Factors and Cardiac Rehabilitation Programme Delivery and Referral Patterns. International Journal of Nursing Practice, 21, 749-755. https://doi.org/10.1111/ijn.12337
|
[22]
|
Baalbaki, H.A. and Bell, D.S. (2007) Insulin Resistance and Thrombogenesis: Recent Insights and Therapeutic Implications. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 13, 679-686. https://doi.org/10.4158/EP.13.6.679
|
[23]
|
Saito, S., Teshima, Y., Fukui, A., et al. (2014) Glucose Fluctuations Increase the Incidence of Atrial Fibrillation in Diabetic Rats. Cardiovascular Research, 104, 5-14. https://doi.org/10.1093/cvr/cvu176
|
[24]
|
Henriksson, K.M., Farahmand, B., Johansson, S., Asberg, S., Terent, A. and Edvardsson, N. (2010) Survival after Stroke—The Impact of CHADS2 Score and Atrial Fibrillation. International Journal of Cardiology, 141, 18-23.
https://doi.org/10.1016/j.ijcard.2008.11.122
|
[25]
|
Goto, S., Bhatt, D.L., Rother, J., et al. (2008) Prevalence, Clinical Profile, and Cardiovascular Outcomes of Atrial Fibrillation Patients with Atherothrombosis. American Heart Journal, 156, 855-863.
https://doi.org/10.1016/j.ahj.2008.06.029
|
[26]
|
Kim, Y.D., Park, B., Cha, M.J., et al. (2010) Stroke Severity in Concomitant Cardiac Sources of Embolism in Patients with Atrial Fibrillation. Journal of the Neurological Sciences, 298, 23-27. https://doi.org/10.1016/j.jns.2010.08.011
|
[27]
|
Hart, R.G., Pearce, L.A., Miller, V.T., et al. (2000) Cardioembolic vs. Noncardioembolic Strokes in Atrial Fibrillation: Frequency and Effect of Antithrombotic Agents in the Stroke Prevention in Atrial Fibrillation Studies. Cerebrovascular Diseases, 10, 39-43. https://doi.org/10.1159/000016023
|
[28]
|
Evans, A., Perez, I., Yu, G. and Kalra, L. (2001) Should Stroke Subtype Influence Anticoagulation Decisions to Prevent Recurrence in Stroke Patients with Atrial Fibrillation? Stroke, 32, 2828-2832.
https://doi.org/10.1161/hs1201.099520
|
[29]
|
Hankey, G.J. and Eikelboom, J.W. (2010) Antithrombotic Drugs for Patients with Ischaemic Stroke and Transient Ischaemic Attack to Prevent Recurrent Major Vascular Events. The Lancet Neurology, 9, 273-284.
https://doi.org/10.1016/S1474-4422(10)70038-7
|